Targeted News Service

MassBio CEO Flags Potential 100% Pharma Tariffs, Looming NIH Budget Cuts
April 03, 2026

WASHINGTON, April 3 -- MassBio CEO and President Kendalle Burlin O'Connell is monitoring an expected Section 232 national security announcement from the Trump administration regarding 100% tariffs on patented drugs and ingredients. The move targets pharmaceutical companies without White House pricing agreements, raising significant supply chain and financial concerns for smaller biotech manufacturers.

-- Marlyn T. Vitin, Targeted News Service

* * *

Her . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form